liver carcinoma (Cancer)
Information
- Disease name
- liver carcinoma
- Disease ID
- DOID:686
- Description
- "A liver cancer that has_material_basis_in epithelial cells." [url:http\://en.wikipedia.org/wiki/Carcinoma, url:http\://en.wikipedia.org/wiki/Liver_cancer]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02465060 | Active, not recruiting | Phase 2 | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | August 17, 2015 | December 31, 2025 |
| NCT04682847 | Active, not recruiting | Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers | November 19, 2020 | December 31, 2024 | |
| NCT00328770 | Completed | Phase 2/Phase 3 | De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma | December 1996 | March 2006 |
| NCT01482442 | Completed | Phase 3 | SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma | December 2011 | April 2016 |
| NCT01717729 | Completed | Phase 3 | Hepatocellular Carcinoma Treated With Iodine-125 Implantation | January 2000 | October 2012 |
| NCT02305459 | Completed | CIRSE Registry for SIR-Spheres Therapy | November 2014 | January 1, 2020 | |
| NCT02424955 | Completed | N/A | Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation | November 18, 2014 | June 30, 2022 |
| NCT03178409 | Completed | Combined HCC-MFCCC | January 1, 2004 | May 15, 2017 | |
| NCT03775863 | Completed | AFP Model and Liver Transplantation. | November 11, 2017 | December 12, 2018 | |
| NCT05681234 | Completed | N/A | Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma | August 24, 2022 | December 20, 2022 |
| NCT04825470 | Not yet recruiting | N/A | Liver Transplantation for Unresectable GIST Liver Metastases | May 2022 | December 2025 |
| NCT04443322 | Recruiting | N/A | Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) | September 19, 2020 | December 31, 2025 |
| NCT04288323 | Recruiting | Phase 4 | Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis | April 27, 2018 | July 30, 2024 |
| NCT06144385 | Recruiting | Phase 1 | A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma | March 24, 2022 | December 2024 |
| NCT04955808 | Suspended | Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | February 7, 2017 | December 31, 2026 | |
| NCT00767234 | Terminated | Permission to Collect Blood Over Time for Research | August 2008 | October 2011 | |
| NCT00791544 | Terminated | Phase 1/Phase 2 | Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma | November 2008 | November 2009 |
| NCT01020812 | Terminated | Phase 1/Phase 2 | Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma | September 2009 | March 2014 |
| NCT01380392 | Unknown status | The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma | February 2011 | February 2012 | |
| NCT01272557 | Unknown status | Phase 2 | Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial | December 2010 | December 2014 |
| NCT01744639 | Withdrawn | N/A | Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation | December 2012 | May 2016 |
- Disase is a (Disease Ontology)
- DOID:3571
- Cross Reference ID (Disease Ontology)
- NCI:C7927
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0279000
- Exact Synonym (Disease Ontology)
- Liver and Intrahepatic bile duct carcinoma